Literature DB >> 21211739

Impaired awareness of hypoglycaemia: a review.

A J Graveling1, B M Frier.   

Abstract

Impaired awareness of hypoglycaemia (IAH) is an acquired complication of insulin therapy, which affects people with type 1 and insulin-treated type 2 diabetes mellitus, whereby the ability to perceive the onset of hypoglycaemia becomes diminished or absent. Deficiencies of the counter-regulatory hormonal responses to hypoglycaemia usually co-exist. The development of IAH and counter-regulatory failure greatly increases the risk of severe hypoglycaemia. Scoring systems have been developed that can be used in the clinical setting and assist with identification of this group of individuals at risk of severe hypoglycaemia. The mainstay of treatment of IAH is the scrupulous avoidance of hypoglycaemia.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21211739     DOI: 10.1016/S1262-3636(10)70470-5

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  29 in total

1.  Impaired awareness of hypoglycemia in a man with type 1 diabetes.

Authors:  Gilles Plourde; Agnes V Klein; Robert Dent
Journal:  CMAJ       Date:  2014-02-10       Impact factor: 8.262

Review 2.  Hypoglycemia in older people - a less well recognized risk factor for frailty.

Authors:  Ahmed H Abdelhafiz; Leocadio Rodríguez-Mañas; John E Morley; Alan J Sinclair
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

3.  IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES.

Authors:  Yu Kuei Lin; Man Hung; Anu Sharma; Owen Chan; Michael W Varner; Gitana Staskus; Simon J Fisher
Journal:  Endocr Pract       Date:  2019-03-13       Impact factor: 3.443

4.  Is there a need to measure preand post-capillary blood glucose following a cardiac exercise class?

Authors:  Tim P Grove; Neil E Hill
Journal:  Br J Cardiol       Date:  2020-12-02

5.  Continuous glucose monitors: use of waveform versus glycemic values in the improvements of glucose control, quality of life, and fear of hypoglycemia.

Authors:  Tomas C Walker; Carolyn B Yucha
Journal:  J Diabetes Sci Technol       Date:  2014-03-22

Review 6.  Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

Authors:  Brian M Frier
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

7.  A distinct hypothalamus-to-β cell circuit modulates insulin secretion.

Authors:  Ioannis Papazoglou; Ji-Hyeon Lee; Zhenzhong Cui; Chia Li; Gianluca Fulgenzi; Young Jae Bahn; Halina M Staniszewska-Goraczniak; Ramón A Piñol; Ian B Hogue; Lynn W Enquist; Michael J Krashes; Sushil G Rane
Journal:  Cell Metab       Date:  2022-02-01       Impact factor: 27.287

Review 8.  Update on strategies limiting iatrogenic hypoglycemia.

Authors:  Aldo Bonaventura; Fabrizio Montecucco; Franco Dallegri
Journal:  Endocr Connect       Date:  2015-06-22       Impact factor: 3.335

Review 9.  Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review.

Authors:  Markolf Hanefeld; Eva Duetting; Peter Bramlage
Journal:  Cardiovasc Diabetol       Date:  2013-09-21       Impact factor: 9.951

10.  Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.

Authors:  Marc Evans; Kamlesh Khunti; Muhammad Mamdani; Claus B Galbo-Jørgensen; Jens Gundgaard; Mette Bøgelund; Stewart Harris
Journal:  Health Qual Life Outcomes       Date:  2013-06-03       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.